Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

185

ATC	Name	B/G	Ingredients	Dosage	Form	Price
C09CA06	BLOPRESS	B	Candesartan cilexetil - 8mg	8mg	Tablet	847,965 L.L
C09CA06	ANDESART 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	498,566 L.L
C09CA06	ARKANDA 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	639,925 L.L
C09CA06	CANDESARTAN BIOGARAN	G	Candesartan cilexetil - 8mg	8mg	Tablet, scored	434,061 L.L
N03AX22	FYCOMPA	B	Perampanel - 8mg	8mg	Tablet, film coated	10,180,812 L.L
G04CA04	SILOSIN	B	Silodosine - 8mg	8mg	Capsule	1,927,454 L.L
G04CA04	SILODOSINE ARROW	G	Silodosine - 8mg	8mg	Capsule	732,394 L.L
G04CA04	SILODOSINE BIOGARAN	G	Silodosine - 8mg	8mg	Capsule	555,007 L.L
N05AB03	PERPHENAZINE	G	Perphenazine - 8mg	8mg	Tablet, scored	624,567 L.L
A04AA01	ZOFRAN	B	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	6,329,648 L.L
A04AA01	APO-ONDANSETRON	G	Ondansetron - 8mg	8mg	Tablet	1,491,665 L.L
A04AA01	NAUSETRON	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, scored	1,023,880 L.L
A04AA01	NOZENTRIX	G	Ondansetron - 8mg	8mg	Tablet, film coated	1,151,865 L.L
A04AA01	ONDAKEY	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	4,489,778 L.L
A04AA01	ONDANSETRON BIOGARAN	G	Ondansetron - 8mg	8mg	Tablet, coated	1,307,559 L.L
A04AA01	ONDANSETRON MEDIS	G	Ondansetron (HCl dihydrate) - 8mg	8mg	Tablet, film coated	748,520 L.L
A04AA01	NOZAMET	G	Ondansetron - 8mg	8mg	Film, orodispersible	6,075,448 L.L
A04AA01	ONDANSETRON ARROW	G	Ondansetron - 8mg	8mg	Tablet, orodispersible	1,280,682 L.L
A04AA01	ONZETRAN OD	G	Ondansetron - 8mg	8mg	Tablet, orodispersible	1,023,880 L.L
A04AA01	ZONETRON ODT	G	Ondansetron - 8mg	8mg	Tablet, orodispersible	998,283 L.L
N07BC01	BUPENSAN	G	Buprenorphine - 8mg	8mg	Tablet	1,259,180 L.L
N07BC01	BUPRENORPHINE ARROW	G	Buprenorphine - 8mg	8mg	Tablet	1,115,389 L.L
N07BC01	BUVIDAL	B	Buprenorphine - 8mg	8mg	Injectable solution prolonged release	8,524,771 L.L
N07CA01	VASOSERC	G	Betahistine dihydrochloride - 8mg	8mg	Tablet	1,334,884 L.L
S01LA05	EYLEA	BioTech	Aflibercept - 8mg/0.07ml	8mg/0.07ml	Injectable solution	78,332,387 L.L
N04BC09	NEUPRO	B	Rotigotine - 8mg/24h	8mg/24h	Patch	12,394,936 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	3,547,744 L.L
H02AB02	DEXAMED	G	Dexamethasone - 8mg/2ml	8mg/2ml	Injectable solution	486,471 L.L
H02AB02	DEXAMEDIS FORT	G	Dexamethasone Phosphate - 8mg/2ml	8mg/2ml	Injectable solution	43,003 L.L
H02AB02	DEXAMETHASONE SODIUM PHOSPHATE USP - EIPICO	G	Dexamethasone (sodium phosphate) - 8mg/2ml	8mg/2ml	Injectable solution	185,450 L.L

...

185